Eikonoklastes Therapeutics
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $3.2M
Investors
- 3
About Eikonoklastes Therapeutics
Eikonoklastes Therapeutics, Inc.Founded in 2019 in Cincinnati, US, Eikonoklastes Therapeutics specializes in biopharmaceutical development, particularly in gene therapy. The company was co-founded by Bruce Halpryn and Samuel Lee, with Halpryn serving as CEO.Eikonoklastes Therapeutics™ develops biopharmaceutical solutions targeting neurodegenerative diseases. Their lead product, ET-101/SynCav1, is a novel gene therapy designed to enhance neuromuscular signaling by overexpressing Caveolin-1 in neurons, with applications in conditions such as ALS, Alzheimer’s, and Parkinson’s.The revenue model of Eikonoklastes Therapeutics™ revolves around collaborations with healthcare institutions for clinical trial support and product development. Their business structure includes direct partnerships with medical centers, focusing on their gene therapy product ET-101. The company aims to expand its product offerings and may target new markets in Western Europe and parts of Asia by 2023, seeking to enhance its therapeutic offerings in the neurodegenerative disease landscape.
Who invested in Eikonoklastes Therapeutics
3 investors across 2 rounds
See all investors in Eikonoklastes Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eikonoklastes Therapeutics
Who invested in Eikonoklastes Therapeutics?
Eikonoklastes Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eikonoklastes Therapeutics raised?
Eikonoklastes Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Eikonoklastes Therapeutics last raise money?
Eikonoklastes Therapeutics's most recent round on record is a Series A, in Apr 2021.
What does Eikonoklastes Therapeutics do?
Eikonoklastes Therapeutics, Inc.
Where is Eikonoklastes Therapeutics headquartered?
Eikonoklastes Therapeutics is headquartered in Cincinnati, US.
Which VCs invest in companies like Eikonoklastes Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eikonoklastes Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Eikonoklastes Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.